The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Rowland Charles A Jr since year 2005.
The trader's CIK number is 1383292.
At the time of this reporting, Rowland Charles A Jr is the Director of Bind Therapeutics, Inc .
(stock ticker symbol BIND).
See this page for all insider trading activities at Bind Therapeutics, Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2016-08-26||BIND||Bind Therapeutics, Inc||Option Ex||15,000||.44||6,600|
|2014-01-08||VPHM||Viropharma Inc||Option Ex||28,753||10.06||289,197|
|2013-12-27||VPHM||Viropharma Inc||Option Ex||4,540||5.91||26,831|
|2013-12-18||VPHM||Viropharma Inc||Option Ex||49,006||8.91||436,643|
|2012-03-07||VPHM||Viropharma Inc||Option Ex||30,638||12.73||390,021|
|2012-03-01||VPHM||Viropharma Inc||Option Ex||70,000||8.91||623,700|
|2011-03-14||VPHM||Viropharma Inc||Option Ex||35,000||7.38||258,475|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Rowland Charles A Jr (Director of Bind Therapeutics, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.